Technologies
BRI Pharma developed novel technologies to define the risk or prodromal dementia using blood. BRI Pharma also has three drug seeds to prevent progression of dementia from prodromal state.
Mission
The drugs prevent accumulation of misfolding proteins accounting Alzheimer’s, Parkinson’s and Lewy body diseases
Vision
The novel diagnosis technologies support the healthy aging in brain functions for long-life in human
![](https://bri-pharma.jp/wp-content/uploads/2021/10/画像1.png)
Novelty and benefits of B-refine (Diagnoisis technology)
![](https://bri-pharma.jp/wp-content/uploads/2021/10/画像2.png)
Novelty and Superiority of BRI-301
![](https://bri-pharma.jp/wp-content/uploads/2021/10/画像3.png)